ReviewHuman vaccines & immunotherapeutics2025
Addressing male HPV vaccination in China: A narrative review of challenges and opportunities.
Review in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Human papillomavirus awareness and vaccination willingness among male community residents in Beijing based on the Health Belief Model.Human vaccines & immunotherapeutics · 2026Article
- HPV vaccine awareness, uptake, intention, and influencing factors among medical students in Anhui, China: A cross-sectional study.Human vaccines & immunotherapeutics · 2026Article
- Knowledge and attitudes of medical students about human papillomavirus (HPV) and HPV vaccine: A cross-sectional survey in Inner Mongolia, China.Human vaccines & immunotherapeutics · 2026Article
- Quality and content evaluation of male HPV infection on Bilibili and TikTok: a cross-sectional study.Scientific reports · 2026Article
- Incidence, recurrence, and determinants of sexually transmitted infections among people with HIV: a multicenter cohort study in China, 2010-2024, with implications for integrated HIV-STI prevention across the Western Pacific.The Lancet regional health. Western Pacific · 2026Article
- Factors influencing HPV vaccination intention and uptake behaviors among medical students based on the health belief model and vaccine hesitancy theory: a cross-sectional study.Frontiers in public health · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus (HPV) poses significant health risks to men, including genital warts and HPV-related cancers. In China, the recent approval of HPV vaccination for males aged 9-26 marks an important step toward gender-inclusive prevention. However, challenges remain in promoting vaccine acceptance among men due to the perception of HPV as a "women's disease," limited public awareness, cultural stigma, and low perceived susceptibility, particularly among heterosexual men. Men who have sex with men (MSM) may demonstrate relatively higher willingness to vaccinate. Vaccine confidence may be influenced by historical vaccine safety concerns and the spread of misinformation, particularly online. Although healthcare provider recommendations may significantly improve uptake, past studies indicate that many men report receiving little or no guidance. This review highlights the need for early education, culturally appropriate messaging, and engagement with trusted community figures. Gender-neutral vaccine promotion and appeals to social responsibility may enhance confidence and uptake among Chinese men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.